Olanzapine Pamoate Depot Versus Oral Olanzapine on Treatment Outcomes in Outpatients With Schizophrenia
Clinical trial NCT00320489 · COMPLETED
Trial details
- NCT number
- NCT00320489
- Sponsor
- Eli Lilly and Company
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2006-04-01
- Primary completion
- 2009-09-01
- Enrollment
- 524
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.